Submitted Papers
No individual can be first author on more than one abstract. If no author on the
abstract is a member, please provide the sponsor's name and e-mail address.
Fellows, Regular, or Corporate Members can sponsor an unlimited number of
abstracts. If they are not an author on the abstract, the sponsor's name and e-mail
address must be entered. Associate Members cannot serve as sponsor on abstracts
on which they are not listed as an author. Student or In-Training Members
can submit one abstract on which they are first author but cannot sponsor any other
abstracts. Should you need a list of members, please contact the Executive Office
of CPDD. You need to get permission from the potential sponsor before listing him/her,
and you should provide a copy of the abstract to the sponsor. The character limit is
2300 for the text of the abstract. This includes the title, authors, institutions and all spaces
and carriage returns.
Subject Matter
Papers can be on any aspect of drug abuse or addiction or on the actions of
drugs of abuse. They should contribute to our knowledge of the agents involved
in drug abuse, including their molecular biology, chemistry, pharmacological
action, biological disposition, abuse potential, safety or clinical usefulness.
Contributions concerning research on neurobiology, epidemiology, prevention,
public health aspects, or management and treatment of drug dependence are
also encouraged.
Procedures for Submission
There are four categories of abstract submissions: Original Research,
Program Descriptions, Theoretical/Commentary, and Literature Review. All
categories must include an Aim, a Conclusion and a “Supported by” statement.
Original Research must include Methods and Results sections. These
sections are optional for the other categories. Details of each category are
provided below.
Original Research includes all prospective and retrospective studies that
involve testing a hypothesis by collecting and analyzing data. Abstracts of basic
research or clinical studies must specify the following: hypothesis, species,
number of subjects, procedures, results, statistical analyses, and importance
of findings (conclusions). Scholarly historical or sociological reports must
specify hypothesis, procedures, analyses, results, and a concluding statement
describing the implications of the study. Please note that results must be
explicitly described in the abstract, and that abstracts reporting no results will
likely be rejected. Recently completed studies, as yet unpublished, are
preferred and any in press work must have a publication date after July 1, 2009.
Program Descriptions are reserved for non-experimental abstracts that simply
provide a narrative of a research program or a theme that is being pursued. No
data are required and the abstract can discuss potential plans for pursuing
new research directions.
Theoretical/Commentary abstracts can be about any topic related to drug
abuse including (but not limited to) policy, trends in the field, treatment
strategies, mechanisms of action, and methodological issues. No data are
required.
Literature Review abstracts should provide a scholarly discussion of a specific
topic via a review of the current literature. Critical review abstracts need not
have data per se but will need to have a concluding statement about the
authors’ findings.
All submissions will be peer-reviewed, and time, space, and programmatic
needs will be considered in decisions of acceptance or rejection, and in
assignment to oral or poster sessions. First authors will receive e-mail
notification of acceptance with the date and time of presentation. No individual
can be first author on more than one abstract. Abstracts will be available for
viewing and downloading at cpdd.org before the meeting. The plenary and
annual reports will be published separately.
Use the Electronic Abstract Submission process to submit abstracts for the
2009 CPDD Annual Meeting. (Link will be available at the beginning of November.)
Follow the online instructions given for each page.
The abstract fee is payable by credit card. Abstracts submitted for oral or
poster sessions must be entered by December 1, 2008. Please read the
abstract guidelines and follow the instructions carefully. Failure to follow the
instructions will result in rejection of your abstract.
Search 
